Airway (AWM) - Net Assets
Based on the latest financial reports, Airway (AWM) has net assets worth zł-10.08 Million PLN (≈ $-2.77 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł12.89 Million ≈ $3.55 Million USD) and total liabilities (zł22.97 Million ≈ $6.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Airway (AWM) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł-10.08 Million |
| % of Total Assets | -78.17% |
| Annual Growth Rate | N/A |
| 5-Year Change | -179.34% |
| 10-Year Change | -260.51% |
| Growth Volatility | 62.28 |
Airway - Net Assets Trend (2014–2024)
This chart illustrates how Airway's net assets have evolved over time, based on quarterly financial data. Also explore AWM total asset value for the complete picture of this company's asset base.
Annual Net Assets for Airway (2014–2024)
The table below shows the annual net assets of Airway from 2014 to 2024. For live valuation and market cap data, see AWM stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł-24.32 Million ≈ $-6.69 Million |
-84.14% |
| 2023-12-31 | zł-13.21 Million ≈ $-3.63 Million |
+1.06% |
| 2022-12-31 | zł-13.35 Million ≈ $-3.67 Million |
-155.85% |
| 2021-12-31 | zł23.90 Million ≈ $6.58 Million |
-22.03% |
| 2020-12-31 | zł30.65 Million ≈ $8.44 Million |
-6.63% |
| 2019-12-31 | zł32.83 Million ≈ $9.04 Million |
-3.46% |
| 2018-12-31 | zł34.01 Million ≈ $9.36 Million |
+34.69% |
| 2017-12-31 | zł25.25 Million ≈ $6.95 Million |
+3.93% |
| 2016-12-31 | zł24.29 Million ≈ $6.69 Million |
+60.35% |
| 2015-12-31 | zł15.15 Million ≈ $4.17 Million |
-65.89% |
| 2014-12-31 | zł44.41 Million ≈ $12.22 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Airway's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4961796276.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł25.06 Million | % |
| Other Comprehensive Income | zł4.17 Million | % |
| Other Components | zł1.17 Million | % |
| Total Equity | zł-24.32 Million | 100.00% |
Airway Competitors by Market Cap
The table below lists competitors of Airway ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pharmacielo Ltd
V:PCLO
|
$8.16 Million |
|
Axiom Properties Ltd
AU:AXI
|
$8.17 Million |
|
LabGenomics Co. Ltd
KQ:084650
|
$8.17 Million |
|
Eurasia Fonciere Investissements Société Anonyme
PA:EFI
|
$8.17 Million |
|
Bhandari Hosiery Exports Limited
NSE:BHANDARI
|
$8.15 Million |
|
Falmaco Nonwoven Industri PT Tbk
JK:FLMC
|
$8.15 Million |
|
Ladangbaja Murni PT Tbk
JK:LABA
|
$8.15 Million |
|
Bayan Mining and Minerals Ltd
AU:BMM
|
$8.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Airway's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -13,207,000 to -24,319,000, a change of -11,112,000.
- Net loss of 11,735,000 reduced equity.
- Other comprehensive income decreased equity by 3,660,999.
- Other factors increased equity by 4,283,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-11.73 Million | -48.25% |
| Other Comprehensive Income | zł-3.66 Million | -15.05% |
| Other Changes | zł4.28 Million | +17.62% |
| Total Change | zł- | % |
Book Value vs Market Value Analysis
This analysis compares Airway's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | zł1.15 | zł0.29 | x |
| 2015-12-31 | zł0.31 | zł0.29 | x |
| 2016-12-31 | zł0.45 | zł0.29 | x |
| 2017-12-31 | zł0.43 | zł0.29 | x |
| 2018-12-31 | zł0.58 | zł0.29 | x |
| 2019-12-31 | zł0.56 | zł0.29 | x |
| 2020-12-31 | zł0.52 | zł0.29 | x |
| 2021-12-31 | zł0.41 | zł0.29 | x |
| 2022-12-31 | zł-0.26 | zł0.29 | x |
| 2023-12-31 | zł-0.22 | zł0.29 | x |
| 2024-12-31 | zł-0.33 | zł0.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Airway utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -97791.67%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-6.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -4.11% | 0.00% | 0.00x | 1.01x | zł-6.27 Million |
| 2015 | -10.03% | 0.00% | 0.00x | 1.51x | zł-3.03 Million |
| 2016 | -8.30% | -3536.84% | 0.00x | 1.19x | zł-4.45 Million |
| 2017 | 2.51% | 0.00% | 0.00x | 1.13x | zł-1.89 Million |
| 2018 | -5.98% | -220.85% | 0.02x | 1.34x | zł-5.43 Million |
| 2019 | -4.15% | -462.93% | 0.01x | 1.33x | zł-4.64 Million |
| 2020 | -7.74% | -923.74% | 0.00x | 1.68x | zł-5.44 Million |
| 2021 | -29.47% | -117400.00% | 0.00x | 1.86x | zł-9.43 Million |
| 2022 | 0.00% | -39909.47% | 0.02x | 0.00x | zł-36.40 Million |
| 2023 | 0.00% | -27300.00% | 0.00x | 0.00x | zł-1.96 Million |
| 2024 | 0.00% | -97791.67% | 0.00x | 0.00x | zł-9.30 Million |
Industry Comparison
This section compares Airway's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $57,127,000
- Average return on equity (ROE) among peers: 12.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Airway (AWM) | zł-10.08 Million | -4.11% | N/A | $8.15 Million |
| Mercator Medical S.A. (MRC) | $57.13 Million | 12.02% | 0.75x | $122.06 Million |
About Airway
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; Oral Care for intubated hospital … Read more